250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Biotech VC (Venture Capital) Funds in United Kingdom in May 2025

A list of 50 VC (Venture Capital) funds that invest in Biotech startups based in United kingdom. We rank investors based on the number of investments they made in Biotech companies from United kingdom. We update this investor list every month.

Top 50 Biotech VC (Venture Capital) Funds in United Kingdom in May 2025

Investor Biotech United Kingdom investments
UK Innovation & Science Seed Fund 55
Parkwalk Advisors 43
Scottish Enterprise 38
Oxford Science Enterprises 38
SOSV 37
Oxford Technology Management 34
Scottish Investment Bank 32
Catapult Ventures 30
Oxford Science Enterprises 26
Mercia Fund Managers 26
Oxford Capital 22
Development Bank of Wales 22
Epidarex Capital 22
Future Planet Capital 21
Archangels 21
AlbionVC 20
IP Group 20
Sofinnova Partners 19
Wren Capital 19
Deepbridge Capital 19
Newable Private Investing 18
GM&C Life Sciences Fund 18
Northstar Ventures 17
Kelvin Capital 16
Syncona Partners LLP 16
O2h Ventures 16
TRICAPITAL 16
Octopus Ventures 16
SFC Capital 15
Hoxton Ventures 15
Cambridge Angels group 14
Kindred Capital 14
M Ventures 14
Cambridge Innovation Capital 14
Par Equity 14
IQ Capital 13
Business Growth Fund 13
Nesta Ventures 13
24 Haymarket 13
YFM Equity Partners 12
Wellcome Trust 12
Calculus Capital 12
SR One 11
Mercia Asset Management 11
Longwall Venture 11
Amadeus Capital Partners 11
Meltwind Advisory 11
Selvedge Venture 10
Esperante Ventures 10
Dementia Discovery Fund 10
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
UK Innovation & Science Seed Fund VC Fund · Harwell, Oxfordshire, United Kingdom · 11 investments in the past 12 months
UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Funding Round, Series A
  • United Kingdom, United States
Portfolio highlights
  • Ikarovec — Ikarovec is developing novel gene therapies to treat major ophthalmic indications.
  • Antiverse — Designing biologics for 100 challenging targets
  • iFast Diagnostics — iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial resistance.
Parkwalk Advisors VC Fund · London, England, United Kingdom · 11 investments in the past 12 months
Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Seed, Series A, Series B
  • United Kingdom, United States, Philippines
Portfolio highlights
  • Diffblue — Diffblue Cover uses next generation autonomous AI to automate unit testing so that Java development teams can build better applications faster
  • illumion — Illumion develops high-throughput optical tools to accelerate battery material development
  • Brainomix — Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providingreal-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
Scottish Enterprise VC Fund · Glasgow, Glasgow City, United Kingdom · 21 investments in the past 12 months
Scotland's business advice, support and funding agency. Explore our products and services to find the right support for your business and apply online today.
Show more
Investment focus
  • Biotechnology, Software, Health Care
  • Grant, Funding Round, Seed
  • United Kingdom, United States, Japan
Portfolio highlights
  • CSignum — CSignum specializes in wireless communications solutions, digitization of subsea assets, and actionable insights for ocean industries.
  • Sisaltech — Sisaltech a natural fiber from the Agave plant, is durable, biodegradable, and has low environmental impact in production. Sisaltech makes the use of these in building insulation a very eco-friendly choice.
  • Scotmas Group — Scotmas are specialists in Chlorine Dioxide (ClO2) generators & dosing systems for drinking water treatment, Legionella control and SWRO.
Oxford Science Enterprises VC Fund · Oxford, Oxfordshire, United Kingdom · 9 investments in the past 12 months
Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking onchallenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.
Show more
Investment focus
  • Health Care, Biotechnology, Software
  • Seed, Series A, Series B
  • United Kingdom, United States, Finland
Portfolio highlights
  • FluoRok — By employing our patented technology, we can produce fluorochemicals without the production of toxic and highly dangerous hydrofluoric acid
  • Neu Health — Neu Health enables clinicians, care givers and patients to tackle this growing challenge with cutting-edge digital technologies designed to make the latest care accessible for all, improving outcomes today and accelerating future breakthroughs.
  • Salience Labs — Salience Labs is building a hybrid photonic-electronic chip for AI. We have designed a massively parallel, ultra-high-throughput Photonic Tensor Processing Unit. Photonics allows data to be modulated at up to 100 GHZ, and allows for high levels of parallelization using multiplexing. We integrate this photonic unit into a SoC architecture designedto exploit its high throughput for AI inference. Salience Labs technology is based on decades of research collaboration between Oxford University and the University of Münster, Germany.
SOSV VC Fund · Princeton, New Jersey, United States · 75 investments in the past 12 months
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Seed, Convertible Note, Pre-Seed
  • United States, India, United Kingdom
Portfolio highlights
  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Oxford Technology Management VC Fund · Oxford, Oxfordshire, United Kingdom
Oxford Technology's SEIS fund and EIS fund enable private investors to access high growth technology startup opportunities and support UK innovation. SEIS and EIS tax reliefs offer downside protection, whilst gains can be tax free.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Seed, Funding Round, Series A
  • United Kingdom, United States
Portfolio highlights
  • OxCan — Enabling curative cancer treatment through early detection
  • CryoLogyx — Assay Ready Cells - Discover CryoLogyx's advanced cryopreservation solutions, optimized for cell-based assays in drug discovery. Simply thaw with cell culture medium, and they are ready for use within 24 hours post-thaw.
  • Metacarpal — Metacarpal design upper-limb prosthetics without compromise. We aim to make the most robust, functional hand prosthesis that people love wearing because it works so effectively and looks so beautiful. Be proud to show your artificial side!
Scottish Investment Bank VC Fund · Glasgow, Glasgow City, United Kingdom
Speak with our Entrepreneurship and Investment teams, who can help you find sources of finance, engage with funders and secure investment to grow your business.
Show more
Investment focus
  • Software, Biotechnology, Health Care
  • Funding Round, Seed, Series A
  • United Kingdom, United States, France
Portfolio highlights
  • Bio-Images Drug Delivery — BDD Pharma combine drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and new innovative pharmaceutical products. Rapid parallel clinical testing with SWIFT significantly reduces time from product concept to clinical success.
  • IOTech — Discover IOTech Systems, the open edge data platform for developing, deploying, and managing Industrial Edge applications at scale. Find out more here.
  • Administrate — Administrate is a comprehensive, configurable training management platform that helps organizations streamline enterprise learning and development. Organize, deliver, plan, automate, analyze, and scale your training program effectively -- all through one system. Deliver multi-modality learner experiences, maximize training resources, anddemonstrate business results with insight-rich reporting. Hundreds of organizations serving millions of learners choose Administrate to manage their training program.
Catapult Ventures VC Fund · Leicester, Leicester, United Kingdom · 3 investments in the past 12 months
The team behind Catapult Ventures are among the most experienced venture capital investors in the UK.Their experience spans a range of sectors from healthcare and pharmaceuticals to luxury consumer brands, manufacturing and software, as well as all stages: from start-ups and pre-revenue IP developers to company floatation and billions of poundsin revenue. Their administration team is equally experienced with each member having more than 10 years experience in a venture capital environment.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Funding Round, Seed, Series A
  • United Kingdom, United States, Israel
Portfolio highlights
  • Path Robotics — We create manufacturing robots that autonomously scan, position, and weld your parts without the need for skilled welders or robot programmers.
  • Pickle Robot — We make robots that unload trucks without retrofitting the warehouse
  • Anello Photonics — Anello Photonics is founded by pioneers in silicon photonics and inertial navigation. The patented Anello SiPhOG gyroscope offers an affordable mass-market sensor with true Optical Gyroscope performance. The company is headquartered in Silicon Valley and funded by leading venture capital firms.
Oxford Science Enterprises VC Fund · Oxford, Oxfordshire, United Kingdom · 9 investments in the past 12 months
Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking onchallenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.
Show more
Investment focus
  • Health Care, Biotechnology, Software
  • Series A, Seed, Series B
  • United Kingdom, United States, The Netherlands
Portfolio highlights
  • FluoRok — By employing our patented technology, we can produce fluorochemicals without the production of toxic and highly dangerous hydrofluoric acid
  • Neu Health — Neu Health enables clinicians, care givers and patients to tackle this growing challenge with cutting-edge digital technologies designed to make the latest care accessible for all, improving outcomes today and accelerating future breakthroughs.
  • Salience Labs — Salience Labs is building a hybrid photonic-electronic chip for AI. We have designed a massively parallel, ultra-high-throughput Photonic Tensor Processing Unit. Photonics allows data to be modulated at up to 100 GHZ, and allows for high levels of parallelization using multiplexing. We integrate this photonic unit into a SoC architecture designedto exploit its high throughput for AI inference. Salience Labs technology is based on decades of research collaboration between Oxford University and the University of Münster, Germany.
Mercia Fund Managers VC Fund · Henley In Arden, Warwickshire, United Kingdom · 2 investments in the past 12 months
Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Seed, Funding Round, Series A
  • United Kingdom, United States, Hungary
Portfolio highlights
  • Administrate — Administrate is a comprehensive, configurable training management platform that helps organizations streamline enterprise learning and development. Organize, deliver, plan, automate, analyze, and scale your training program effectively -- all through one system. Deliver multi-modality learner experiences, maximize training resources, anddemonstrate business results with insight-rich reporting. Hundreds of organizations serving millions of learners choose Administrate to manage their training program.
  • Warwick Acoustics — Warwick Acoustics believe in creating products that are designed from the ground up in order to deliver the best personal audio listening experience available to customers.
  • Melius Cyber — Melius Cyber continuously monitors an organization's IT network, testing security and protecting it from the latest threats.
Oxford Capital VC Fund · Oxford, Oxfordshire, United Kingdom · 5 investments in the past 12 months
Helping individuals and institutions invest in Venture Capital, Infrastructure and Media companies since 1999.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Funding Round, Seed, Series A
  • United Kingdom, United States, France
Portfolio highlights
  • Egregious — Egregious is an advanced research & intelligence lab established to defend humans from AI and provides narrative intelligence solutions across the public and private sectors to protect organisations and online users from malign influence using AI-driven data acquisition, insights, and engagement.
  • TurinTech AI — TurinTech is a leader in Evolutionary AI Optimisation. We are a research-driven deep tech company founded in 2018 based in London. We envision an intelligent and efficient business world powered by scalable AI. We automate multi-objective optimisation to help businesses scale AI efficiently: build AI quicker, run AI faster, deploy AI greener.TurinTech builds upon over 10 years’ research in optimisation. We are professors, data scientists and engineers from prestigious universities across the globe who are actively collaborating with world-leading academic institutions to create breakthroughs.Learn more about scaling AI at https://turintech.ai/
  • Arcube — We make sure all travellers, frequent and infrequent, make the most of travel loyalty programs, using our data-driven approach, airlines can understand their customers and provide hyper-personalised offerings to boost value and retention.Arcube uses a data-driven approach to make the most of airline loyalty programs for both frequent andinfrequent flyers. Our software allows airlines to understand their customers and provide hyper-personalised offerings to boost value and retention at no extra cost to the airline.
Development Bank of Wales VC Fund · Cardiff, Cardiff, United Kingdom · 20 investments in the past 12 months
Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Seed, Funding Round, Debt Financing
  • United Kingdom, Australia, United States
Portfolio highlights
  • Driverly — Driverly is an Insurtech based in Cardiff, Wales, with a mission to bring insurance to the 21st century. We offer AI-powered Insurance Intelligence at different stages of the customer life cycle.
  • nisien.ai — Industry-leading artificial and human intelligence for effective and ethical online safeguarding with Nisien AI.
  • Lumin Solutions
Epidarex Capital VC Fund · Bethesda, Maryland, United States
Epidarex Capital invests in early-stage, high growth life science and health technology companies in under-ventured markets. Its international team is led by Sinclair Dunlop, Kyp Sirinakis and Liz Roper. With offices in the United States and United Kingdom Epidarex Capital’s investors represent a cross-section of leading universities, internationalcorporations, development agencies and financial institutions. Epidarex was created to meet the need for more sector-specific financial backing for young companies, including spin-outs from leading research universities.
Show more
Investment focus
  • Biotechnology, Therapeutics, Health Care
  • Series A, Seed, Series B
  • United Kingdom, United States, Germany
Portfolio highlights
  • Theolytics — Theolytics is a biotechnology company harnessing viruses to combat cancer. A step-change in the oncolytic viral therapy field, our phenotypic screening Platform enables the discovery and development of efficacious, targeted candidates suitable for intravenous delivery and optimised for a chosen patient population. In addition to advancing aninternal Pipeline of programs spanning both solid and liquid tumours, we are establishing select strategic partnerships to expand and accelerate pipeline development.
  • Curve Therapeutics — Curve has developed an innovative screening platform that is transforming the discovery of first-in-class therapeutics. The platform allows functional screening of diverse, genetically encoded Microcycle™ libraries against a broad range of disease-associated targets that are present in their native conformation inside a mammalian cell. Curve isdeploying this platform to build a pipeline of novel cancer drugs.
  • Enterprise Therapeutics — Enterprise Therapeutics is a drug discovery company dedicated to the researchand development of novel therapies for the treatment of respiratory diseases.In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlyingmechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life.
Future Planet Capital VC Fund · London, England, United Kingdom · 6 investments in the past 12 months
Brilliant Ideas. Brilliant People. Brilliant Minds.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Seed, Funding Round, Convertible Note
  • United Kingdom, United States, Canada
Portfolio highlights
  • Ikarovec — Ikarovec is developing novel gene therapies to treat major ophthalmic indications.
  • Antiverse — Designing biologics for 100 challenging targets
  • Inicio AI — A specialist Income & Expenditure trained virtual agent delivering improved CX and robust results
Archangels VC Fund · Edinburgh, Edinburgh, City of, United Kingdom · 3 investments in the past 12 months
Established in 1992. Archangels is the oldest continuously operating business angel syndicate in the World. Investing in IP-rich tech & life sciences companies in Scotland, UK.
Show more
Investment focus
  • Software, Biotechnology, Health Care
  • Funding Round, Seed, Series A
  • United Kingdom, United States
Portfolio highlights
  • CSignum — CSignum specializes in wireless communications solutions, digitization of subsea assets, and actionable insights for ocean industries.
  • Administrate — Administrate is a comprehensive, configurable training management platform that helps organizations streamline enterprise learning and development. Organize, deliver, plan, automate, analyze, and scale your training program effectively -- all through one system. Deliver multi-modality learner experiences, maximize training resources, anddemonstrate business results with insight-rich reporting. Hundreds of organizations serving millions of learners choose Administrate to manage their training program.
  • iGii — Integrated Graphene enable better products with a revolutionary design for manufacture process producing the world's highest quality pure 3D Graphene Foam, Gii.
AlbionVC VC Fund · London, England, United Kingdom · 7 investments in the past 12 months
AlbionVC supports visionary founders with long-term capital and scale-up expertise. Founded in 1996, today we are partners to UK early-stage B2B software and healthcare companies. AlbionVC manages c. $1 billion of venture funds, currently invested in over 50 companies. AlbionVC is the technology investment arm of Albion Capital Group LLP, which isauthorised and regulated by the Financial Conduct Authority.
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Series A, Funding Round, Seed
  • United Kingdom, United States, France
Portfolio highlights
  • Diffblue — Diffblue Cover uses next generation autonomous AI to automate unit testing so that Java development teams can build better applications faster
  • IONATE — IONATE Ltd. is a technology company developing next-generation Hybrid Intelligent Transformers.
  • Infact Systems — Infact Systems is a company that focuses on bringing affordability and credit information into the 21st century. They facilitate the sharing of real-time, contextual data, primarily in the banking industry. Their mission is to increase responsible financial behavior by providing real-time data for modern credit. They offer integration andcustomization services for HPZone, particularly in terms of connecting with external laboratory systems. Infact Systems also provides services to help women take control of their finances.
IP Group VC Fund · London, England, United Kingdom · 6 investments in the past 12 months
IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.
Show more
Investment focus
  • Health Care, Biotechnology, Information Technology
  • Seed, Series A, Funding Round
  • United Kingdom, United States, Australia
Portfolio highlights
  • Lumai — Lumai delivers fully optical computing for a quicker, smarter and more sustainable world. Lumai power the revolution of fully optical computing by working at the nexus of photonics and machine learning.
  • Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
  • Diffblue — Diffblue Cover uses next generation autonomous AI to automate unit testing so that Java development teams can build better applications faster
Sofinnova Partners VC Fund · Paris, Ile-de-France, France · 20 investments in the past 12 months
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • France, United States, United Kingdom
Portfolio highlights
  • Latent Labs — Latent Labs is making biology programmable to transform health and sustainability for the benefit of all.We are a frontier AI lab building foundational models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizingexisting enzymes, and advancing genetic engineering.Contact us to work with us today.
  • Signadori Bio — Signadori Bio is the next-generation cellular immunotherapy for cancer cure.This has culminated in the creation of a groundbreaking biotech venture in the cell and gene space that is set to advance innovative approaches in oncology.
  • Forth Therapeutics — Forth Therapeutics is a biotechnology company dedicated to advancing precision treatments for fibrosis.
Wren Capital VC Fund · London, England, United Kingdom
Wren is an angel investor in science, engineering and software. They founded Wren in 2011 and have invested in 50 companies so far.Wren is well known in the early stage investment community and has co-invested with a wide range of both angel and institutional investors. From software and semiconductors to genome editing, and from medical devicesto satellites, they are interested in sectors where technical ingenuity and hard work can produce long term value. They look for people with a deep understanding of their markets. The founders they invest in are smart and they get things done.Wren typically invests £50,000 to £200,000 per funding round. Difficult problems take time to solve, so they are patient with their investments. Their aim is to get deals done and they take a pragmatic approach to doing so.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Funding Round, Series A
  • United Kingdom
Portfolio highlights
  • Spotta — Spotta's smart pest systems help pest control monitor and identify pests. Solutions for hospitality, care homes, agriculture, farming and forestry.
  • MitoRx Therapeutics — Developing revolutionary mitochondrial-protective therapeutics which reverse mitochondrial dysfunction to arrest decline in muscular dystrophy and neurodegeneration. MitoRx Therapeutics' first-in-class first-in-target platform has potential to arrest the progression of some of the most challenging diseases.
  • Monument Therapeutics — Monument Therapeutics is a biotechnology company intended to develop drugs to treat serious diseases of the central nervous system.
Deepbridge Capital VC Fund · Chester, Cheshire, United Kingdom
Deepbridge is a different kind of investment manager. They work closely with financial advisers and investors to design innovative products, ranging from investment in technology growth companies to asset-backed renewable energy projects. They also partner with innovative and committed management teams to help UK based companies realise theirpotential and become successful leading-edge businesses.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Seed, Funding Round, Series A
  • United Kingdom, Australia, Singapore
Portfolio highlights
  • AI-Sight — AI-Sight is a startup that is developing an AI diabetic retinal screening system to deliver WHO-recommended diabetic eye screening services.
  • Microplate Dx — Safeguarding against the spread of antimicrobial resistance worldwide.
  • GenoMe Diagnostics — GenoME Diagnostics - We are developing a blood test for an earlier and more accurate diagnosis of ovarian cancer.GenoME Diagnostics .
Newable Private Investing VC Fund · London, England, United Kingdom
Newable: Helping over 20,000 businesses thrive annually with tailored financial products, advice, and flexible workspace solution
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Seed, Funding Round, Series A
  • United Kingdom, United States
Portfolio highlights
  • Delta g — Delta g Limited is a quantum technology and gravity gradiometry company. A spin-out from the University of Birmingham our technology has applications in industries as varied as civil engineering, infrastructure, defence, rail, navigation and resource exploration. Experts from science, engineering an
  • Weldfast — Weldfast is a manufacturer and supplier of welding consumables, abrasives, chemicals, premium gas equipment, and safety products.
  • EarSwitch — Empowering new ways to control and connect with the world through in-ear biometric switch and sensor technology
GM&C Life Sciences Fund VC Fund · Alderley Edge, Cheshire, United Kingdom
The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Seed, Funding Round, Series A
  • United Kingdom, Italy, Germany
Portfolio highlights
  • ScubaTx — ScubaTx is a breakthrough organ preservation device organ transplant. The ScubaTx device will leverage world-leading expertise in software design to commercialise a proven but unexploited organ preservation technique, Persufflation. ScubaTx will offer healthcare providers significant net savings, an
  • Flynotes — Flynotes is a digital software platform helping dentists deliver personalised patient care
  • QV Bioelectronics — Manchester-based start-up QV Bioelectronics is developing innovative electrotherapy devices for the treatment of certain types of brain tumours.
Northstar Ventures VC Fund · Newcastle Upon Tyne, Newcastle upon Tyne, United Kingdom · 12 investments in the past 12 months
Northstar Ventures invests venture capital in early and later stage, high growth companies tackling global challenges, focusing on climate tech and healthy ageing.
Show more
Investment focus
  • Software, Health Care, E-Commerce
  • Seed, Funding Round, Series A
  • United Kingdom, United States, Indonesia
Portfolio highlights
  • VRAI — First and foremost, they are a content creation company specialising in virtual reality production. They are visual storytellers embracing this new medium as a way of creating immersive, engaging content.Their pioneering methodology takes elements from our diverse background. We use techniques from narrative cinema, from visual effects, fromexhibition design, from gaming, from brand management and combine them in new exciting ways to help you tell your story.
  • Nanovery — Founded by scientists specialised in Nanotechnology, Medicinal Chemistry and Artificial Intelligence, we are on a mission to enable early detection of cancer through a rapid and affordable blood test Backed by academics at top universities, clinicians, industrial leaders, and Entrepreneur First.
  • MySalesCoach — MySalesCoach offers Despite overwhelming evidence that sales coaching has the greatest impact on rep development and success, managers typically devote less than 5% of their time to coaching a team that craves and deserves coaching to reach their full potential.
Kelvin Capital VC Fund · Glasgow, Glasgow City, United Kingdom · 4 investments in the past 12 months
We invest venture capital in to globally ambitious companies which have the potential to deliver a significant return to our investors
Show more
Investment focus
  • Health Care, Biotechnology, Manufacturing
  • Seed, Funding Round, Series A
  • United Kingdom, United States
Portfolio highlights
  • novosound — Novosound is an award winning Scottish sensors company utilising thin-film processes to eliminate conventional limitations in ultrasound sensors.
  • Chromacity — Chromacity manufacture the next generation of ultrafast lasers. Discover our fixed wavelength femtosecond lasers and picosecond OPOs.
  • Biotangents — Biotangents develops veterinary diagnostic tests to detect infectious diseases in livestock (bovine viral diarrhoea (BVD), mastitis, bovine respiratory disease (BRD), brucellosis) using our highly adaptable molecular diagnostic technology, Moduleic Sensing.
Syncona Partners LLP VC Fund · London, England, United Kingdom · 6 investments in the past 12 months
Syncona is a FTSE250 company focused on founding, building and funding healthcare companies to deliver transformational treatments to patients in areas of high unmet need.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Seed
  • United Kingdom, United States, Switzerland
Portfolio highlights
  • Purespring Therapeutics — Purespring Therapeutics is an AAV gene therapy company focused on the kidney globally.
  • Resolution Therapeutics — Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.
  • Yellowstone Biosciences — Yellowstone seeks to identify a novel class of frequently expressed antigens that can be therapeutically targeted, With the potential to dramatically improve patient outcomes.
O2h Ventures VC Fund · 2 investments in the past 12 months
Focused on seeding early stage biotech therapeutics and related AI opportunities. The fund will invest in companies qualifying under EIS and covering novel...
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Seed, Series A, Pre-Seed
  • United Kingdom, Hungary
Portfolio highlights
  • Healx — At Healx we use AI drug discovery to develop new treatments for rare diseases. We bring treatments from prediction to patient.
  • Atelerix — Discover Atelerix's hypothermic hydrogels for eco-friendly, reliable cell preservation and ambient temperature shipping. Ensure fresh, viable cell samples today.
  • ViaNautis — Precision Solutions
TRICAPITAL VC Fund · Melrose, Scottish Borders, The, United Kingdom · 2 investments in the past 12 months
The TRICAPITAL Syndicate is a business angel cohort of entrepreneurs, CEOs and business leaders who have founded, funded and built companies
Show more
Investment focus
  • Biotechnology, Software, Health Care
  • Funding Round, Seed, Series B
  • United Kingdom, France
Portfolio highlights
  • HonuWorx — HonuWorx is a technology company providing autonomous systems aimed at lowering both expenses and the environmental impact of operating robotic systems. The company's software technology is an edge-cloud architected communications and control platform that enables geographically distributed stakeholders to see data, collaborate, supervise, andcontrol robotic systems that are beyond line-of-sight.
  • Sellmyartworks — EzelDotz - Buy and Sell Contemporary Art Online | Art Marketplace. Curated collection of Sculptures, Limited Editions and Originals.
  • Heero Technologies — Heero Technologies, the leading independent energy platform for making net zero homes a reality
Octopus Ventures VC Fund · London, England, United Kingdom · 22 investments in the past 12 months
We provide venture capital investment for the people, ideas and industries that will change the world. Learn about what we do and the kind of founders we back.
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Series A, Seed, Series B
  • United Kingdom, United States, Germany
Portfolio highlights
  • Amplience — The shopping experience platform for generating, creating and delivering content with context
  • Orbex Space — Founded in 2015, Orbex is Europe’s leading private launch services company, focused entirely on supporting the needs of the small satellite industry.Orbex has developed one of the most advanced, low carbon, high performance micro-launch vehicles in the world. They launch customer satellites into polar and sun-synchronous low Earth orbits from aunique, modern launch location in the heart of the European continent.They offer a flexible core launch service and a wide suite of supporting services that make life easier for customers. Their European location means shorter supply lines, easier communications and reduced operational costs. Their advanced launch vehicle means higher reliability, more flexible mission profiles and a regular, scheduled launch service.
  • Zendo Energy — Zendo Energy is dedicated to the mission of decarbonising computing power. The company aims to empower data centres to become smarter, more efficient, and prepared for the increasing future demand of computing by leveraging advanced software solutions. Their platform utilizes real-time analytics and predictive tools to optimise energy consumption,reduce emissions, and integrate renewable energy sources such as wind and solar, thereby supporting the transition to sustainable digital infrastructure. This mission addresses the urgent need to reduce the carbon footprint of data centres amid the exponential growth of AI and computing workloads globally
SFC Capital VC Fund · London, England, United Kingdom · 23 investments in the past 12 months
Discover the UK's leading SEIS Fund, offering tax-efficient investments in innovative startups. Join thousands of savvy investors and raise capital for your business with SFC Capital.
Show more
Investment focus
  • Software, Artificial Intelligence, Information Technology
  • Pre-Seed, Seed, Funding Round
  • United Kingdom, United States, Canada
Portfolio highlights
  • Returnal — Supercharge your sustainability journey with our buy-back tech. We invite you to own products through their 2nd and 3rd lifecycles through our buy-back model. Find out more today...
  • UNA Watch — UNA Watch is a wearable tech startup that develops modular and repairable GPS sports watches. The company's flagship product is designed to provide accurate tracking for activities such as running, cycling, and hiking, featuring dual-frequency GPS, an altimeter, accelerometer, advanced heart rate sensor, and a 10-day battery life. The watchemploys a modular design, allowing users to easily replace or upgrade components, thereby promoting sustainability and reducing electronic waste. Additionally, it utilizes USB-C charging to minimize the need for proprietary cables.
  • CareLoop Health — CareLoop, an innovation emerging from the University of Manchester, furnishes patients with digital support resources while simultaneously providing healthcare professionals with the means to monitor and track patient symptoms.
Hoxton Ventures VC Fund · London, England, United Kingdom · 6 investments in the past 12 months
Hoxton Ventures focuses on startups that either disrupt existing industries or invent entirely new market categories. Hoxton typically invests between $500,000 and $5 million into pre-seed, seed, and Series A stage companies, and follows its capital through the life of the company. The firm is based in London and invests all across Europe.
Show more
Investment focus
  • Artificial Intelligence, Software, Information Technology
  • Seed, Series A, Funding Round
  • United Kingdom, United States, Canada
Portfolio highlights
  • Cogna — Cogna offers an AI-powered SaaS platform that streamlines the integration of data across several business domains.
  • Formance — Numary makes it easy to build complex money-moving software with its open-source ledger & Numscript programming language.
  • Deblock — Forget your bank account: Get an IBAN, a Debit Card and a Non-custodial Crypto wallet. Deposit any crypto on your current account. Exchange Euro and Crypto without any limit.
Cambridge Angels group VC Fund · Cambridge, Cambridgeshire, United Kingdom · 5 investments in the past 12 months
The Cambridge Angels are a group of high-net worth investors who have proven experience as successful entrepreneurs in internet, software, technology and bio-technology. Members invest in and mentor high quality start-up and early-stage companies in these sectors in the Cambridge (UK) area and throughout the UK.Typical funding requirements thatthe Cambridge Angels meet are in the range of £50,000 to £500,000 - although it is worth noting that several of their portfolio companies have received more than £1m in funding from their Members over several funding rounds.Their Members have been responsible for a large number of the “Cambridge Phenomenon” success stories over recent years. Therefore, in addition to providing funding for early-stage companies, the Cambridge Angels also offer start-ups the considerable benefit of a wide range of expertise, contacts and directly relevant experience in establishing and growing entrepreneurial businesses successfully.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Seed, Funding Round, Series A
  • United Kingdom, United States, Estonia
Portfolio highlights
  • FLIT — Unfold Your Next Adventure. Discover the compact folding electric bike purpose-built for commuters, urban explorers and weekend tourers.
  • Wilder Sensing — Wilder Sensing analyses audio and other data sources to produce actionable insights into the status and trends of biodiversity on your site.
  • AVIEL Intelligence — AVIEL Intelligence provides a proactive, AI-driven solution to prevent customers from making payments to scammers and block fraudulent transactions.
Kindred Capital VC Fund · London, England, United Kingdom · 10 investments in the past 12 months
A new model for Venture Capital where every founder we back becomes a co-owner of the fund
Show more
Investment focus
  • Software, Biotechnology, Information Technology
  • Seed, Series A, Series B
  • United Kingdom, United States, Germany
Portfolio highlights
  • Cakewalk — Cakewalk enables IT & Security teams to monitor all SaaS apps used by their employees, run compliant access flows, securely on- and offboard people, and be IT audit-ready.
  • Latent Labs — Latent Labs is making biology programmable to transform health and sustainability for the benefit of all.We are a frontier AI lab building foundational models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizingexisting enzymes, and advancing genetic engineering.Contact us to work with us today.
  • Sohar Health — Streamline patient intake and boost revenue with Sohar's real-time insurance verification and eligibility solutions. Automate workflows, reduce claim denials, and improve conversion rates with accurate, fast, and reliable tools. Book a demo today to transform your patient onboarding process.
M Ventures VC Fund · Amsterdam, Noord-Holland, The Netherlands · 18 investments in the past 12 months
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Seed
  • United States, United Kingdom, Switzerland
Portfolio highlights
  • Biolinq — Introducing a revolutionary platform for metabolic health.
  • ChEmpower — ChEmpower is an advanced materials company that develops chemically reactive, abrasive-free planarization pads to improve chip yields and sustainability in semiconductor manufacturing.
  • Corvic AI — Corvic AI is pioneering a new era of Data-Centric AI Cognitive Infrastructure by transforming raw enterprise data into AI-ready intelligence.
Cambridge Innovation Capital VC Fund · Cambridge, Cambridgeshire, United Kingdom · 7 investments in the past 12 months
As a team, we have a passion for science and its potential to drive change. Through our expertise and our position in one of the country's most powerful science and technology ecosystems, we're able to identify and support the most promising entrepreneurs in knowledge intensive businesses and help them achieve their vision.With our financial backing and expert guidance, we're excited to enable the pioneers in life sciences and deep tech to create world-leading companies whose unique ideas bring financial success and global impact.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Seed
  • United Kingdom, United States, Ireland
Portfolio highlights
  • Forefront RF — Forefront RF tunable duplexer aims to expand the accessibility and global market reach of all mobile devices by simplifying RFFE design.
  • Salience Labs — Salience Labs is building a hybrid photonic-electronic chip for AI. We have designed a massively parallel, ultra-high-throughput Photonic Tensor Processing Unit. Photonics allows data to be modulated at up to 100 GHZ, and allows for high levels of parallelization using multiplexing. We integrate this photonic unit into a SoC architecture designedto exploit its high throughput for AI inference. Salience Labs technology is based on decades of research collaboration between Oxford University and the University of Münster, Germany.
  • TRIMTECH Therapeutics — Transformative treatments for CNS and inflammatory disorders by selectively destroying disease-causing protein aggregates
Par Equity VC Fund · Edinburgh, Edinburgh, City of, United Kingdom · 8 investments in the past 12 months
Founded in 2008, Par Equity is a venture capital firm that backs the most innovative, high growth technology companies in the North of the UK. Based in Edinburgh, Par invests across Northern England, Northern Ireland and Scotland.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Funding Round, Series A, Seed
  • United Kingdom, United States, Brazil
Portfolio highlights
  • CSignum — CSignum specializes in wireless communications solutions, digitization of subsea assets, and actionable insights for ocean industries.
  • Partful — Make sure customers get the right parts first time, every time with digital 3D parts catalogue software and digital work instructions.
  • Watercycle Technologies — Watercycle Technologies specialized in the development of high-yield, low-cost mineral extraction, and water treatment systems. Its core technology, capable of treating highly concentrated water, is an end-to-end solution encompassing mineral extraction, concentration, and crystallization.
IQ Capital VC Fund · Cambridge, Cambridgeshire, United Kingdom · 9 investments in the past 12 months
IQ Capital is a Cambridge & London-based VC firm that invests in ‘deep tech’ companies capable of dominating their respective markets on a global scale. Initial investments at Seed and Series A range from £0.5m to £10m, with capacity for follow-on investment up to £30m through the Growth Fund. The team has achieved over 30 exits including toApple, Huawei, Google and Oracle.
Show more
Investment focus
  • Software, Artificial Intelligence, Machine Learning
  • Seed, Series A, Funding Round
  • United Kingdom, United States, The Netherlands
Portfolio highlights
  • Nyobolt — The latest innovations in battery technology have the potential to reduce charging times from hours to minutes. Join us on our journey.
  • IONATE — IONATE Ltd. is a technology company developing next-generation Hybrid Intelligent Transformers.
  • Alpine Eagle — The Sentinel Counter-UAS System is an air-to-air sensor & interceptor network designed to detect, classify, and intercept unmanned aerial systems (UAS)
Business Growth Fund VC Fund · London, England, United Kingdom · 34 investments in the past 12 months
BGF is the most active equity investor in the UK and Ireland, providing long-term, minority investment to growing companies.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Funding Round, Series A, Private Equity
  • United Kingdom, Ireland, United States
Portfolio highlights
  • OCL Vision — Expert eye care from trusted UK specialists. From laser vision correction to cataract surgery, discover life-changing treatments.
  • Phlux Technology — We develop, manufacture and supply innovative communication and vision components
  • Maxion Therapeutics — Maxion Therapeutics helps in learning transformative therapies. It uses this technology to deliver long-acting, safe, and effective medications against previously inaccessible targets.
Nesta Ventures VC Fund · London, England, United Kingdom
We bring bold ideas to life to change the world for good.
Show more
Investment focus
  • Biotechnology, Medical Device, Medical
  • Funding Round, Seed, Series A
  • United Kingdom, United States
Portfolio highlights
  • Citymart — Citymart powers cities to deliver services that work. Following best practices developed with leading cities around the world, Citymart connects cities and revolutionizes the way cities frame needs, complete procurements, and improve service delivery. Over 100 cities in 35 countries have adopted Citymart tools and methods to-date.
  • Featurespace — Featurespace™ is the world leader in Enterprise Financial Crime prevention for fraud and Anti-Money Laundering. Featurespace invented Adaptive Behavioral Analytics and Automated Deep Behavioral Networks, both of which are available through the ARIC™ platform, a real-time machine learning software that risk scores events in more than 180 countriesto prevent fraud and financial crime.ARIC™ Risk Hub uses advanced, explainable anomaly detection to enable financial institutions to automatically identify risk, catch new fraud attacks and identify suspicious activity in real-time. More than 30 major global financial institutions are using ARIC to protect their business and their customers. Publicly announced customers include HSBC, TSYS, Worldpay, NatWest, Contis, Danske Bank, ClearBank, Akbank and Permanent TSB.
  • Radio Physics Solutions — PASAR123 merupakan landasan utama bandar slot nomor 1 di indonesia memiliki fasilitas slot deposit pulsa tanpa potongan penarikan sangat mudah dan cepat.
24 Haymarket VC Fund · London, England, United Kingdom · 2 investments in the past 12 months
24Haymarket is an investment network which included several highly-experienced private equity and venture capital investors, seasoned entrepreneurs, and senior operators. Investing up to £5 million in growth companies in the UK and Europe. They invested their own capital in direct alignment with entrepreneurs and actively support their growthagenda and join the board of the companies in which they invest. Since inception in 2011, 24Haymarket has invested in more than 50 high-growth businesses.
Show more
Investment focus
  • Health Care, Software, Information Technology
  • Funding Round, Seed, Series A
  • United Kingdom, United States
Portfolio highlights
  • CyberOwl — Helping maritime fleet operators gain visibility, cybersecurity and cyber compliance of shipboard systems with IMO 2021.
  • Optalitix — Optalitix's data driven products and expertise allow you to move your models to the cloud and improve underwriting efficiency.
  • onHand — The volunteering and climate impact platform for businesses and individuals. Help your local communities and have global impact.
YFM Equity Partners VC Fund · London, England, United Kingdom · 4 investments in the past 12 months
YFM Equity Partners is an independent private equity business owned by its senior management and investment team. They invest up to £10 million of equity through offices in Leeds, London, Manchester, Birmingham and Sheffield.
Show more
Investment focus
  • Software, Information Technology, Biotechnology
  • Funding Round, Private Equity, Series A
  • United Kingdom, United States, Belgium
Portfolio highlights
  • Xapien — Xapien delivers automated insight reports on companies and individuals in minutes, so you can make informed business decisions quickly and with confidence.
  • StormHarvester — The leading provider of analytics for wastewater utilities. Combining hyperlocal rainfall with AI to prevent pollution and flooding.
  • Audiological Science — Audiological Science is a medical equipment manufacturing company that produces hearing aids.
Wellcome Trust VC Fund · London, England, United Kingdom
Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science. It was founded in 1936 and headquartered in London, England.
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Grant, Series C, Funding Round
  • United States, United Kingdom, Germany
Portfolio highlights
  • RenBio — RenBio develops antibody-based therapeutic solutions for the treatment of cancer and inflammatory diseases. RenBio's proprietary MYO technology involves in the development of antibody therapeutic that helps in treating rare diseases, viral infections, autoimmune diseases, and more by using DNA blueprint and antibody factory.
  • Vaxxas — Vaxxas develops and commercializes needle-free vaccine delivery system. Vaxxas was incorporated in 2011 and is based in Brisbane, Australia.
  • Feinstein Institute for Medical Research — Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes ofbehavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.
Calculus Capital VC Fund · London, England, United Kingdom · 5 investments in the past 12 months
At Calculus Capital they are specialists in creating and managing tax efficient private equity funds for the individual. Funds that are ideal for today's market - offering generous tax benefits, and significant growth potential within a sensible risk profile.They look to make £2-5 million investments in established companies with provenmanagement teams and a successful product or service. Their entrepreneurial flair, combined with their experience and sound commercial judgement has resulted in a diversified investment portfolio and an impressive track record. In June 2013 Calculus Capital was top ranked in the prestigious Martin Churchill Tax Efficient Review for the 6th year in a row. The Government has recently shown its support for EIS funds, by maintaining the five generous tax benefits and widening the scope of EIS investments. These changes benefit Calculus Capital's rigorous and proven strategy. As a result they are experiencing their strongest pipeline of prospective investments yet.
Show more
Investment focus
  • Biotechnology, Software, Health Care
  • Funding Round, Series A, Seed
  • United Kingdom, United States, Ireland
Portfolio highlights
  • Booked It — The all-in-one booking platform for Ticketing, booking, loyalty and marketing, in one powerful, modular solution. Book a Demo Give your...
  • Invizius — Invizius is developing products to help patients on dialysis, cardiopulmonary bypass, ECMO and on other extra-corporeal treatments, to feel better, and suffer fewer complications.
  • Notify Technology — Notify is a trusted health and safety software partner. Save time, drive engagement, demonstrate compliance and proactively reduce risk, with our SHEQ system.
SR One VC Fund · Cambridge, Massachusetts, United States · 10 investments in the past 12 months
SR One Capital Management is a leading trans-Atlantic biotech venture capital firm that partners with top entrepreneurs, scientists and investment partners to seek to build elite biotechnology companies. Our mission is to translate ground-breaking technologies into next generation medicines to benef
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States, United Kingdom, Canada
Portfolio highlights
  • Fore Biotherapeutics — We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
  • Windward Bio — Windward Bio is a clinical-stage drug development company focused on improving outcomes for individuals with advanced immunological diseases, particularly severe respiratory conditions. The company is advancing a monoclonal antibody targeting thymic stromal lymphopoietin (TSLP) into phase 2 development while creating innovative bispecific programsfor various immunological disorders. Led by a team of biopharmaceutical executives, Windward Bio aims to address significant unmet medical needs in this field.
  • Kala Pharmaceuticals — Kala Pharmaceuticals is developing novel treatments for diseases that affect mucosal tissues. The company's proprietary mucus penetrating particle technology dramatically improves drug distribution and pharmacokinetics by uniformly coating the mucosal surface with biocompatible, drug-loaded particles. Kala's formulations achieve high,sustained local drug concentrations with reduced systemic exposure and are delivered in a patient-friendly format. The company's research efforts have demonstrated successful in vivo proof-of-concept in mucosal organs such as the respiratory tract, eye, and cervicovaginal tract, enabling diverse product opportunities that target significant clinical unmet need. Kala is focused on advancing an internal pipeline of products through human proof-of-concept while establishing R&D collaborations with select partners to improve products in their pipelines.
Mercia Asset Management VC Fund · Henley In Arden, Warwickshire, United Kingdom · 2 investments in the past 12 months
Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.
Show more
Investment focus
  • Software, Information Technology, Manufacturing
  • Funding Round, Series A, Seed
  • United Kingdom, United States
Portfolio highlights
  • Netacea — Netacea takes a smarter approach to bot management. Intent Analytics™ powered by machine learning quickly and accurately distinguishes bots from humans to protect websites, mobile apps and APIs from automated threats while prioritising genuine users. Actionable intelligence with data-rich visualisations empowers you to make informed decisions aboutyour traffic. The Netacea approach offers incredible speed, accuracy and transparency, solving the growing problem of credential stuffing and account takeover at scale. The technology is designed to complement existing controls such as WAF rulesets, rate limiting and threat databases to provide a deep analysis of all website visitors, actionable intelligence and real-time threat.The Netacea approach continuously monitors your web traffic to pinpoint the difference in automated bot activity vs genuine visitors, keeping you ahead of evolving bot threats. Choose to automatically block, redirect or challenge automated attacks in real-time, or receive alerts notifying you of potential threats. With access to rich dashboards and data, you can easily identify and stop account takeover attempts early in the attack chain.Learn more at www.netacea.com
  • Semble — The integrated clinical system for managing your patients' medical data and admin tasks.
  • Locate Bio — Locate Bio is a regenerative medicine development company focused on orthobiologics. Locate Bio exists to help surgeons improve the lives of people with debilitating spinal conditions. We are curious about what is possible, but ground all our work in robust scientific evidence. We relentlessly pursue high-value opportunities with clear unmetclinical needs.
Longwall Venture VC Fund · Harwell, Oxfordshire, United Kingdom
Longwall Ventures invests in innovative, UK based, early stage companies in the healthcare, science and engineering sectors
Show more
Investment focus
  • Biotechnology, Medical Device, Health Care
  • Funding Round, Seed, Series A
  • United Kingdom, Germany, Philippines
Portfolio highlights
  • Biofidelity — Unleashing the potential of genomics to transform the world we live in through transformational technologies that remove the noise from genomic analysis.
  • Wayland Additive — Wayland Additive Limited is a West-Yorkshire based company pushing the boundaries of electron beam 3D printing. Wayland’s goal is to develop, manufacture and sell metal Additive Manufacturing (“AM” – 3D printing) machines to industrial end-users such as major players in the aerospace and medical industries.
  • Lightcast Discovery — Flexible control over droplet number, occupancy, location and movement. Enabling efficient, multi-step workflows with unprecedented flexibility.
Amadeus Capital Partners VC Fund · Cambridge, Cambridgeshire, United Kingdom · 8 investments in the past 12 months
Amadeus Capital Partners, Venture Capital For Technology Companies. We Back Entreprenuers To Win. Contact Our Experienced Team Of Investors Today
Show more
Investment focus
  • Software, Artificial Intelligence, Machine Learning
  • Series B, Seed, Series A
  • United Kingdom, United States, Spain
Portfolio highlights
  • Inephany — Inephany is a company focusing on improving the efficiency of AI, particularly neural networks and Large Language Models (LLMs).
  • Safe Intelligence — Safe Intelligence specializes in deep validation AI systems, focusing on enhancing the reliability of artificial intelligence models.
  • iPronics — Discover the power of lossless optical switches for low latency and flexible AI architectures. Increase density and reduce power consumption with our innovative technology.
Meltwind Advisory VC Fund · Cambridge, Cambridgeshire, United Kingdom · 3 investments in the past 12 months
Meltwind Advisory.
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Seed, Funding Round, Series A
  • United Kingdom, United States
Portfolio highlights
  • Natrox — Inotec AMD is a wound-care company that has developed Natrox:tm:, a device that produces a continuous flow of humidified oxygen and directs it to a specially-designed dressing, allowing oxygen to constantly refresh the wound.NATROX:tm: is a battery-powered medical device that produces a continuous flow of pure humidified oxygen from air anddirects it through a fine tube to a specially-designed Oxygen Delivery System (ODS), allowing the oxygen to constantly refresh the wound while allowing free passage of wound fluids (exudate) to pass away from the wound surface for absorption and retention in the normal way.
  • NanoSyrinx — NanoSyrinx is an award-winning, discovery stage biotechnology company based in the UK. We are using synthetic biology approaches to develop protein nanosyringes as a completely novel modality for intracellular delivery of protein and peptide biologic drugs.
  • Shift Bioscience — Explore cutting-edge simulation-guided cell rejuvenation techniques aimed at combating aging-related diseases.
Selvedge Venture VC Fund · London, England, United Kingdom
Selvedge Venture operates as a venture capital firm investing for impact in age-related medical conditions.
Show more
Investment focus
  • Health Care, Biotechnology, Life Science
  • Seed, Pre-Seed, Series A
  • United Kingdom, Singapore
Portfolio highlights
  • Mesh Bio — Mesh Bio is a digital health startup that is transforming chronic disease management through predictive analytics. Mesh Bio works with healthcare providers and stakeholders to provide innovative solutions that transform health screening and disease management. They translate clinical data and numbers into actionable insights that help patientsbetter manage their health, lifestyle and disease risks.
  • Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
  • BIOS — BIOS Health is unlocking the potential of the nervous system in treating chronic disease by using AI-powered neural interfaces that can automatically read and write neural signals.
Esperante Ventures VC Fund · Hoofddorp, Noord-Holland, The Netherlands
A corporate venture investment company focussed on investing in mid to late stage clinical stage therapeutics development companies in North America and Europe
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Funding Round, Series B, Series A
  • United Kingdom, Switzerland, United States
Portfolio highlights
  • Amlo Biosciences — From ground-breaking research to revolutionary prognostics and diagnostics AMLo Biosciences is translating ground-breaking research in cancer biomarkers int ...
  • Acousia Therapeutics — Acousia Therapeutics GmbH is a privately held biotech company based in Tübingen, Germany. Acousia has experience and expertise in identifying and developing small molecule drug candidates for the treatment of hearing loss.Sensory hair cells are the key cells for hearing in the inner ear. Acousia`s approach will help to replace lost hair cells bycellular regeneration originating from supporting cells.ASpherecousia is developing drugs for local application, which will restore hearing in patients who have lost their hearing ability induced by various reasons, e.g. noise trauma, treatment with ototoxic drugs or sudden deafness. In addition, these therapies will have the potential to treat the age-related decrease in hearing capacity.
  • Spiral Therapeutics — Spiral Therapeutics is a clinical stage pharmaceutical company delivering novel therapies for hearing loss. Through the use proprietary therapeutics and drug delivery technologies, Spiral is building a pipeline of advanced therapies in a field with large unmet needs and no approved therapies. Spiral’s lead candidate, LPT99, reached the clinic inDecember 2018. Spiral was launched in early 2016 and is headquartered in Brisbane, CA.
Dementia Discovery Fund VC Fund · London, England, United Kingdom · 5 investments in the past 12 months
SV Health Investors is a specialist healthcare fund manager, investing across multiple stages and sectors. Our goal is to transform healthcare one investment at a time.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Seed, Funding Round
  • United States, United Kingdom, Israel
Portfolio highlights
  • Therini Bio — Therini Bio is developing novel therapeutics based insights into the role of fibrin in driving chronic innate immune activation.
  • Montara Therapeutics — Montara Therapeutics is a precision-medicine neuroscience biotech startup improving safety and efficacy of therapies for people with neurological diseases
  • TRIMTECH Therapeutics — Transformative treatments for CNS and inflammatory disorders by selectively destroying disease-causing protein aggregates
Investors by industry
Investors by country
VC (Venture Capital) Funds in United Kingdom by industry